Determining Ligand Binding and Specificity Within the β2-Integrin Family with a Novel Assay Platform确定β2-整合素家族中配体结合与特异性的新型分析平台BIOMOLECULESIF4.82025-02-070OA
Allosteric targeting resolves limitations of earlier LFA-1 directed modalitiesBIOCHEMICAL PHARMACOLOGYIF5.62023-05-012PRE
Nephrotoxicity of iopamidol is associated with mitochondrial impairment in human cell and teleost modelsTOXICOLOGY AND APPLIED PHARMACOLOGYIF3.42023-05-013OAAI
Design and Characterization of Mutated Variants of the Oncotoxic Parvoviral Protein NS1VIRUSES-BASELIF3.52023-01-112OAAI
Imatinib disturbs lysosomal function and morphology and impairs the activity of mTORC1 in human hepatocyte cell linesFOOD AND CHEMICAL TOXICOLOGYIF3.52022-04-019OAAI
Anti-αLβ2 antibodies reveal novel endocytotic cross-modulatory functionalityBRITISH JOURNAL OF PHARMACOLOGYIF7.72020-03-093OAAI
Downstream effect profiles discern different mechanisms of integrin αLβ2 inhibitionBIOCHEMICAL PHARMACOLOGYIF5.62016-11-015PREAI
A novel multi-parameter assay to dissect the pharmacological effects of different modes of integrin L2 inhibition in whole bloodBRITISH JOURNAL OF PHARMACOLOGYIF7.72015-10-192OAAI